Saltzman Bryan M, Meyer Maximilian A, Weber Alexander E, Poland Sarah G, Yanke Adam B, Cole Brian J
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
Am J Sports Med. 2017 Mar;45(3):550-562. doi: 10.1177/0363546516669934. Epub 2016 Nov 16.
Concomitant anterior cruciate ligament reconstruction and meniscal allograft transplantation (ACLR/MAT) has demonstrated short-term success in small, retrospective cohort studies. Patient- and disease-specific predictors of success after ACLR/MAT are largely unknown.
To (1) prospectively evaluate the subjective and objective clinical and radiographic outcomes after ACLR/MAT and (2) conduct a subgroup analysis to identify patient- or disease-related factors that correlate with failure.
Case series; Level of evidence, 4.
Patient-reported outcomes (PROs) were prospectively collected on 40 patients undergoing concomitant ACLR/MAT. Nineteen athletes responded to return-to-sport data. Clinical data (physical examination including Lachman and pivot-shift testing and KT-1000 arthrometer testing) were obtained on 28 patients who returned for an evaluation, while 24 of those patients additionally had radiographic data (progression of Kellgren-Lawrence [KL] grade and joint-space narrowing) evaluated. Reoperations and failures were documented for all patients at their final follow-up.
The overall cohort of 40 patients had a mean age of 30.3 ± 9.6 years (range, 16.0-54.0 years) and a mean body mass index of 27.7 ± 4.2 kg/m. The mean follow-up time was 5.7 ± 3.2 years (range, 1.7-16.5 years). There were 33 (83%) medial meniscal transplants performed compared with 7 (17%) lateral meniscal transplants. Patients underwent a mean of 2.9 ± 1.9 prior surgical procedures. Nineteen patients underwent concomitant procedures, including, most commonly, 9 hardware removals and 9 osteochondral allografts. There were significant improvements in 11 of 14 PRO measures as well as a 50% return-to-sport rate. Knee stability significantly improved in 28 patients who returned for a physical examination, and KT-1000 arthrometer testing indicated no differences between the affected and unaffected sides at final follow-up (mean, 0.9 ± 1.5 mm [range, -2 to 4 mm] in comparison to contralateral knee at 30 lb of testing; mean, 0.9 ± 1.9 mm [range, -4 to 4 mm] in comparison to contralateral knee at maximum manual strength). Significant improvements were seen in patients with Lachman grade ≥2A at final follow-up (18% vs 97%, respectively; P < .01) and with pivot shift ≥1+ at final follow-up (36% vs 94%, respectively; P < .01) compared with preoperatively. For the 24 patients with radiographic data, no significant joint-space decrease was recorded in the medial compartment for medial MAT-treated patients or the lateral compartment for lateral MAT-treated patients. The mean KL grade increased from 0.7 ± 0.8 to 1.6 ± 0.9 at final follow-up ( P < .01). There were no major (0%) and 2 minor (5%) complications, which constituted early postoperative drainage treated successfully with oral antibiotics. While 35% of patients underwent reoperations, the majority of these were simple arthroscopic debridements and occurred after nearly 4 years from the index surgery. The overall survival rate at final follow-up was 80%. Failures occurred at a mean of 7.3 years, and those who converted to arthroplasty did so at a mean of 8.3 years from the time of index ACLR/MAT. Patients with failed grafts were more frequently associated with workers' compensation claims (38% vs 13%, respectively) and less frequently self-identified as athletes (13% vs 56%, respectively) compared with patients with intact grafts.
Concomitant ACLR/MAT can provide significant improvements in clinical outcomes and enhancement in objective knee stability and was associated with an insignificant degree of radiographic joint-space narrowing changes with a 5-year survivorship of more than 80% for those with data available. Athlete status may be a preoperative predictor of midterm survival.
在小型回顾性队列研究中,前交叉韧带重建与半月板同种异体移植(ACLR/MAT)同期进行已显示出短期成功。ACLR/MAT术后成功的患者及疾病特异性预测因素在很大程度上尚不清楚。
(1)前瞻性评估ACLR/MAT术后的主观和客观临床及影像学结果;(2)进行亚组分析,以确定与失败相关的患者或疾病相关因素。
病例系列;证据等级,4级。
前瞻性收集了40例行ACLR/MAT同期手术患者的患者报告结局(PROs)。19名运动员回复了恢复运动的数据。对28名返回接受评估的患者获取了临床数据(包括Lachman试验和轴移试验的体格检查以及KT-1000关节测量仪测试),其中24名患者还评估了影像学数据(Kellgren-Lawrence [KL]分级进展和关节间隙变窄)。记录了所有患者在最终随访时的再次手术情况和失败情况。
40例患者的总体队列平均年龄为30.3±9.6岁(范围16.0 - 54.0岁),平均体重指数为27.7±4.2 kg/m²。平均随访时间为5.7±3.2年(范围1.7 - 16.5年)。内侧半月板移植33例(83%),外侧半月板移植7例(17%)。患者平均接受过2.9±1.9次先前手术。19例患者接受了同期手术,最常见的包括9例取出内固定和9例骨软骨异体移植。14项PRO指标中的11项有显著改善,恢复运动率为50%。28名返回接受体格检查的患者膝关节稳定性显著改善,KT-1000关节测量仪测试表明在最终随访时患侧与未患侧无差异(30磅测试时,与对侧膝关节相比平均为0.9±1.5 mm [范围 - 2至4 mm];最大手动力量时,与对侧膝关节相比平均为0.9±1.9 mm [范围 - 4至4 mm])。与术前相比,最终随访时Lachman分级≥2A的患者(分别为18%对97%;P <.01)和轴移≥1+的患者(分别为36%对94%;P <.01)有显著改善。对于24名有影像学数据的患者,内侧MAT治疗患者的内侧间室或外侧MAT治疗患者的外侧间室均未记录到显著的关节间隙减小。最终随访时平均KL分级从0.7±0.8增加到1.6±0.9(P <.01)。无严重(0%)和2例轻微(5%)并发症,均为术后早期引流,经口服抗生素成功治疗。虽然35%的患者接受了再次手术,但大多数是简单的关节镜清创术,且发生在初次手术后近4年。最终随访时的总体生存率为80%。失败平均发生在7.3年,转为关节置换的患者从初次ACLR/MAT手术时起平均为8.3年。与移植成功的患者相比,移植失败的患者更频繁地与工伤赔偿申请相关(分别为38%对13%),且较少自认为是运动员(分别为13%对56%)。
ACLR/MAT同期手术可显著改善临床结局,增强膝关节客观稳定性,与影像学关节间隙变窄变化程度不显著相关,有可用数据者5年生存率超过80%。运动员身份可能是中期生存的术前预测因素。